Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney

Arthritis Res Ther. 2016 Oct 12;18(1):236. doi: 10.1186/s13075-016-1150-7.
No abstract available

Publication types

  • Published Erratum